EFM
DGX icon

E Fund Management’s Quest Diagnostics DGX Stock Holding History

E Fund Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$391K Sell
1,843
-115
-6% -$22.6K 0.01% 331
2026
Q1 		$384K Buy
+1,958
New +$380K 0.01% 338
2025
Q2 		$315K Sell
1,752
-278
-14% -$48.3K 0.02% 295
2025
Q1 		$343K Sell
2,030
-336
-14% -$55.2K 0.02% 284
2024
Q4 		$357K Buy
2,366
+1,007
+74% +$157K 0.02% 282
2024
Q3 		$211K Buy
+1,359
New +$203K 0.01% 321
2024
Q2 		– Sell
-1,593
Closed -$212K – 336
2024
Q1 		$212K Buy
+1,593
New +$207K 0.01% 336

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

E Fund Management's DGX Position: Q2 2026 in Review

E Fund Management reduced its Quest Diagnostics (DGX) stake by 5.9% in Q2 2026, selling an estimated $22.6K and leaving 1,843 shares worth $391K. The position accounts for 0.01% of the portfolio, ranked #331.

E Fund Management first reported a position in DGX in Q1 2024 and has held it in 7 quarters since. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • E Fund Management held 1,843 shares of Quest Diagnostics worth $391K as of Q2 2026.
  • E Fund Management sold 115 Quest Diagnostics shares in Q2 2026, an estimated $22.6K.
  • Quest Diagnostics made up 0.01% of E Fund Management's portfolio in Q2 2026, its #331 holding.
  • E Fund Management first reported a position in Quest Diagnostics in Q1 2024 and has held it in 7 quarters since.
  • 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on E Fund Management's 13F filing for Q2 2026, filed 11 Aug 2026.